Composition for prevention and treatment of allergic and/or inflammatory diseases

1. A method of treating an allergic disease comprising:

initially administering an antiallergenic composition comprising at least one arabinogalactan or arabinogalactan protein into a mammal that is in need of such treatment prior to onset of symptoms of the allergic disease, and

administering subsequent doses of said antiallergenic composition to said mammal,

wherein said at least one arabinogalactan or arabinogalactan protein is isolated from at least one grass species or corresponds in its structural arrangement to an arabinogalactan isolatable from at least one grass species,

wherein the allergic disease is selected from the group consisting of IgE-dependent Type I allergic diseases, and

wherein the mammal has an increased risk to develop the allergic diseases relative to the general population based on diagnostic criteria.

2. The method according to claim 1 , wherein the method is configured to treat one or more selected from the group consisting of hay fever, food allergy, asthma, urticaria, neurodermitis, and atopic dermatitis.

3. The method according to claim 1 , wherein the method is configured to treat one or more selected from the group consisting of hay fever and asthma.

4. The method according to claim 1 , wherein the at least one grass is selected from the group consisting of Meadow Foxtail ( Alopecurus pratensis ), timothy grass and timothy grass pollen ( Phleum pratense L), Cock's Foot ( Dactylis glomerata ), Yorkshire Fog ( Holcus lannatus ), English Raygrass ( Lolium perenne ), Smooth Meadow grass ( Poa pratense ), Rye ( Secale cereale ) or grasses from related species and a mixture thereof.

5. The method according to claim 1 , wherein the composition comprises an arabinogalactan selected from the group consisting of compounds of the structure shown in FIG. 1 .

6. The method according to claim 1 , wherein the composition comprises at least one further active ingredient selected from the group consisting of naturally occurring, isolated bacteria of the genus Lactococcus or fragments of said bacteria.

7. The method according to claim 6 , wherein the bacteria are selected from the group consisting of strains of Lactococcus lactis.

8. The method according to claim 1 , wherein the composition comprises at least one further active ingredient comprising humic acid.

9. The method according to claim 1 , wherein the composition is a pharmaceutical composition in form of an aerosol, aqueous solution, suspension, lyophilisate, or powder for nasal or inhalative application.

10. The method according to claim 1 , wherein the composition is in form for nasal or inhalative administration.

11. The method according to claim 1 , wherein the method is suitable for application for an infant (baby) or a pregnant woman, which due to a positive family anamnesis has an increased risk to develop any allergic disease.

12. The method according to claim 1 , wherein the method is suitable for application to a pregnant woman such that said treatment of an infant will be obtained by the application of the composition to the pregnant mother.

13. The method according to claim 1 , wherein the method is suitable for application to an infant.

14. The method according to claim 1 , wherein the composition is administered to a child directly after birth thereof.

15. The method according to claim 1 , wherein the method is suitable for application to a child during the first years of the child's life up to 8-10 years.

16. The method according to claim 1 , wherein the method is suitable for application to a child within the first five years of the child's life.

17. The method according to claim 1 , wherein the method is suitable for application to a child within the first two years of the child's life.